UNSPSC 85503118: Dilation of left external carotid artery with drug-eluting intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of left external carotid artery with drug-eluting intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 037N34Z

UNSPSC 85503118, Dilation of left external carotid artery with drug-eluting intraluminal device, percutaneous approach, is a Commodity code that bears no meaningful relationship to the state and local contract opportunities currently being solicited under this code. The recent postings show activity across independent medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involves interventional vascular procedures or medical devices. The code appears to be a mislabeling or systematic misclassification issue in the state and local procurement systems tagging these opportunities, rather than evidence of genuine procurement activity for carotid artery dilation procedures or intraluminal devices.

State and local issuers posting opportunities under this code include the City of Phoenix Retirement Office (independent medical evaluations for disability determinations), the City of Long Beach (surgical benefit administration), the Washington State Department of Transportation (occupational medical surveillance), Harris County Juvenile Probation Department (emergency and specialty medical services), Collier County Board of County Commissioners (pharmacy benefit management), and the County of Santa Clara Health System (temporary health professional staffing). These span state departments, county governments, and municipalities across Arizona, California, Florida, Texas, and Washington. The absence of any recent opportunities aligned with the code's stated scope—vascular interventions and specialized medical devices—signals that pursuit under this code is not viable. Prospective vendors should verify their actual UNSPSC classifications in state procurement systems before bidding, as the current tagging creates significant classification noise.